by-studio/iStock via Getty Images
ProQR Therapeutics (PRQR) is a Dutch company developing RNA-based therapies for inherited retinal diseases or IRDs. The company was founded by CEO Daniel de Boer and is targeting cystic fibrosis

Click here to view the original article.